Cannabinoid R&D

Extraction Systems for Cannabinoid Research

For research institutions, universities, and pilot-scale API development labs.

Cannabinoid research is accelerating rapidly in the wake of Schedule III rescheduling. Research institutions, universities, and pharmaceutical R&D labs require validated, GMP-documented extraction and isolation systems that can support IND-enabling studies, clinical trial material production, and the analytical method development required for regulatory submissions.

Prodigy's pilot-scale systems are designed specifically for research applications — delivering the same pharmaceutical-grade construction, documentation, and validation infrastructure as commercial systems, in configurations optimized for R&D throughput and flexibility. Every system supports the analytical traceability and process documentation required for FDA and EU regulatory submissions.

Technology Transfer

Designed to support seamless technology transfer from laboratory-scale development to commercial manufacturing. Successful processes developed on Prodigy pilot systems can transition into full-scale commercial production using the same engineering philosophy, documentation standards, and validation approach — reducing tech-transfer risk and accelerating time to market.